The last Recall Enforcement Report for Amlodipine And Olmesartan Medoxomil with NDC 33342-192 was initiated on 02-15-2022 as a Class II recall due to cgmp deviations The latest recall number for this product is D-0632-2022 and the recall is currently terminated as of 02-17-2023 . Public Citizen, a prominent consumer watchdog group, filed a recall petition for the FDA to issue a Benicar recall and ban all the other olmesartan drugs, such as Benicar HCT, Tribenzor, and Azor stating these have been linked to the development of sprue-like enteropathy causing severe diarrhea
Mar 30, 2022 · The MHRA has confirmed that the recall of combined Amlodipine/Olmesartan Medoxomil tablets 10 mg/20 mg, batch number BAD62101A (expiry Feb 24), is for the US market only – while Macleods Pharma
Apr 18, 2023 · Olmesartan side effects
There are several active lawsuits following the global recall of valsartan in 2018 and the discovery of cancer-causing chemicals in the drug
Accuretic and its two generic
Objectives To examine valsartan, losartan and irbesartan usage and switching patterns in the USA, UK, Canada and Denmark before and after July 2018, when the first